NZ622993A - Combination therapy for the treatment of diabetes - Google Patents

Combination therapy for the treatment of diabetes

Info

Publication number
NZ622993A
NZ622993A NZ622993A NZ62299310A NZ622993A NZ 622993 A NZ622993 A NZ 622993A NZ 622993 A NZ622993 A NZ 622993A NZ 62299310 A NZ62299310 A NZ 62299310A NZ 622993 A NZ622993 A NZ 622993A
Authority
NZ
New Zealand
Prior art keywords
treatment
diabetes
combination therapy
therapy
glucose
Prior art date
Application number
NZ622993A
Inventor
Lisa E Wu
Abraham B Woldu
Yin Liang
John Ryan
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/830,479 external-priority patent/US20110009347A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NZ622993A publication Critical patent/NZ622993A/en

Links

Abstract

Disclosed are methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X, said methods comprising administering to a subject in need thereof a therapeutically effective amount of co-therapy comprising (a) metformin or a pharmaceutically acceptable salt thereof; and (b) a compound of formula (I). The present disclosure is further directed to pharmaceutical compositions for the co-therapy of glucose-related disorders.
NZ622993A 2009-07-08 2010-07-07 Combination therapy for the treatment of diabetes NZ622993A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22388109P 2009-07-08 2009-07-08
US12/830,479 US20110009347A1 (en) 2009-07-08 2010-07-06 Combination therapy for the treatment of diabetes
NZ59755910 2010-07-07

Publications (1)

Publication Number Publication Date
NZ622993A true NZ622993A (en) 2015-10-30

Family

ID=55023064

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ622993A NZ622993A (en) 2009-07-08 2010-07-07 Combination therapy for the treatment of diabetes

Country Status (1)

Country Link
NZ (1) NZ622993A (en)

Similar Documents

Publication Publication Date Title
MX2012000488A (en) Combination therapy for the treatment of diabetes.
IL203448A (en) Azabiphenylaminobenzoic acid derivatives for use in the treatment or prevention of a pathological condition or disease susceptible to amelioration by inhibition of dhodh and pharmaceutical compositions comprising them
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
EP2650293A8 (en) [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
EA201100305A1 (en) TREATMENT OF RESPIRATORY DISEASES
TW200806300A (en) New therapeutic combinations for the treatment of depression
UA96076C2 (en) Use of trans-clomiphene
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
PH12014502448A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
IN2012DN02502A (en)
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
WO2010129057A3 (en) Tetracycline compounds
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
WO2010132670A3 (en) Pentacycline compounds
TNSN08506A1 (en) Substituted carboxamides
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
MX336278B (en) Compositions and methods for prevention and treatment of wounds.
MX2012001107A (en) Amide derivative.
MY156278A (en) Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 07 JUL 2017 BY AJ PARK

Effective date: 20160519

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2018 BY CPA GLOBAL

Effective date: 20170601

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2019 BY CPA GLOBAL

Effective date: 20180531

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2020 BY CPA GLOBAL

Effective date: 20190530

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2021 BY CPA GLOBAL

Effective date: 20200529

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2022 BY CPA GLOBAL

Effective date: 20210603

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2023 BY CPA GLOBAL

Effective date: 20220607

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 JUL 2024 BY CPA GLOBAL

Effective date: 20230601